SLC5A2 and myocardial ischemia: Andreadou et al. have reported that SGLT2 inhibitors mitigate acute myocardial ischemia/reperfusion (I/R) injury by attenuating cardiac infarct size, improving left ventricular function, and reducing arrhythmias2.